ARRHYTHMIA RESEARCH TECHNOLOGY INC (MICR) [Rocket]

Overview

ARRHYTHMIA RESEARCH TECHNOLOGY INC (MICR)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
04/13/2020	4	Heinemann Steven D. (10% Owner) has filed a Form 4 on MICRON SOLUTIONS INC /DE/
04/13/2020	3	Heinemann Steven D. (10% Owner) has filed a Form 3 on MICRON SOLUTIONS INC /DE/
04/08/2020	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]:
04/08/2020	8-K	Regulation FD Disclosure
03/30/2020	10-K	Annual Report for the period ended December 31, 2019
03/27/2020	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/27/2020	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12
Revenues	17.5	19.6	20.1	19.6	21.5	24.1	21.3	20.6
Revenue growth	-10.6%	-2.7%	2.4%	-8.6%	-10.7%	12.8%	3.4%	-15.1%
Cost of goods sold	15.7	17.2	17.8	16.7	18.3	19.4	18.3	17.8
Gross profit	1.8	2.3	2.3	2.9	3.2	4.6	3.0	2.8
Gross margin	10.1%	11.9%	11.4%	14.8%	14.7%	19.3%	14.2%	13.5%
Sales and marketing	0.6	0.7	0.8	1.2	1.1	1.0	0.9	0.9
Research and development	0.1	0.1	0.1	0.1	0.2	0.4	0.3	0.5
General and administrative	2.8	2.2	2.4	2.2	2.4	2.3	2.7	3.1
EBITA	-1.7	-0.8	-1.0	-0.5	-0.5	0.9	-1.0	-1.7
EBITA margin	-9.8%	-3.8%	-5.1%	-2.6%	-2.4%	3.7%	-4.5%	-8.2%
Amortization of intangibles	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBIT	-1.7	-0.8	-1.0	-0.5	-0.5	0.9	-1.0	-1.7
EBIT margin	-9.8%	-3.9%	-5.1%	-2.6%	-2.4%	3.7%	-4.5%	-8.2%
Pre-tax income	-2.1	-1.1	-1.4	-0.7	-0.8	0.7	-1.3	-3.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	2.3	-0.9
Tax rate	0.0%		0.1%	0.0%		0.3%		26.9%
Net income	-2.1	-1.1	-1.4	-0.7	-0.4	0.7	-3.5	-6.1
Net margin	-12.2%	-5.6%	-6.7%	-3.6%	-2.0%	2.7%	-16.6%	-29.7%

Diluted EPS	($0.74)	($0.39)	($0.48)	($0.25)	($0.28)	$0.23	($1.30)	($0.86)
Shares outstanding (diluted)	2.9	2.9	2.8	2.8	2.8	2.9	2.7	2.8

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.